Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9471 |
High Similarity |
NPD7251 |
Discontinued |
0.9415 |
High Similarity |
NPD7808 |
Phase 3 |
0.9412 |
High Similarity |
NPD6797 |
Phase 2 |
0.924 |
High Similarity |
NPD7472 |
Approved |
0.9181 |
High Similarity |
NPD7054 |
Approved |
0.9128 |
High Similarity |
NPD7074 |
Phase 3 |
0.908 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8966 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.896 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8895 |
High Similarity |
NPD6166 |
Phase 2 |
0.8895 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8895 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8686 |
High Similarity |
NPD3818 |
Discontinued |
0.8655 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8538 |
High Similarity |
NPD3817 |
Phase 2 |
0.8488 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8439 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8398 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8398 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8378 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8314 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8276 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8266 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8266 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8218 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8208 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8161 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8129 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8092 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8075 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8059 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8057 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8056 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.802 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7989 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7955 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7943 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7923 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.791 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7874 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7869 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7869 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7865 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7845 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7819 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7814 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7803 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7802 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7753 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7747 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7735 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7732 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7727 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7706 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7701 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7677 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7677 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7677 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7673 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7638 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7638 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7612 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD919 |
Approved |
0.7544 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7527 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7409 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD37 |
Approved |
0.7389 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7377 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7377 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7377 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7371 |
Intermediate Similarity |
NPD3750 |
Approved |
0.736 |
Intermediate Similarity |
NPD6534 |
Approved |
0.736 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7356 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD1247 |
Approved |
0.731 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7287 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7251 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7251 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7241 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7168 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7151 |
Intermediate Similarity |
NPD943 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7136 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7129 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7093 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7049 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7037 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD920 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7017 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7017 |
Intermediate Similarity |
NPD2534 |
Approved |
0.701 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.6995 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6965 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6965 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6965 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD1243 |
Approved |
0.6927 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6906 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6889 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6889 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6862 |
Remote Similarity |
NPD5353 |
Approved |
0.6853 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6845 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6842 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD1203 |
Approved |
0.6839 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6836 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6833 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6833 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6831 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6822 |
Remote Similarity |
NPD7930 |
Approved |
0.6821 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6818 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6802 |
Remote Similarity |
NPD7038 |
Approved |
0.6802 |
Remote Similarity |
NPD7039 |
Approved |
0.6798 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6787 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6787 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6769 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6768 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6765 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.676 |
Remote Similarity |
NPD5406 |
Approved |
0.676 |
Remote Similarity |
NPD6099 |
Approved |
0.676 |
Remote Similarity |
NPD6100 |
Approved |
0.676 |
Remote Similarity |
NPD5405 |
Approved |
0.676 |
Remote Similarity |
NPD5408 |
Approved |
0.676 |
Remote Similarity |
NPD5404 |
Approved |
0.6743 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.674 |
Remote Similarity |
NPD2800 |
Approved |
0.6736 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6733 |
Remote Similarity |
NPD4287 |
Approved |
0.6723 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6723 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6722 |
Remote Similarity |
NPD2344 |
Approved |
0.6715 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6706
|
Remote Similarity |
NPD1091 |
Approved |